EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NeuroCognex multimodal brain signal analysis for Alzheimer disease prediction

Priya Govindarajan, M. Ananthu, S. Sarun, Sneha Kashyap, Malathy Batumalay

Discover Applied Sciences · 06.08.2026 · 8 (11)

DOI: 10.1007/s42452-026-09323-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Applied Sciences, online erschienen am 06.08.2026. Verfasst von Priya Govindarajan und 4 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Amrita Vishwa Vidyapeetham, Coimbatore.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease is a progressive neurological condition marked by memory loss and cognitive decline that necessitates precise and timely diagnosis. This proposed method presents NeuroCognex (NCX), a system that uses functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) to diagnose Alzheimer’s disease early by combining multimodal data processing and deep learning. PEARL Neuro dataset, a publicly available dataset consisting of EEG and fMRI recordings was used for training and validating NCX. While fMRI-derived statistical representations provide compact summaries of brain activity, the framework uses sophisticated EEG signal processing techniques, such as band-specific spectrum decomposition and power spectral density estimates, to capture spectral characteristics of EEG signals. By using cross-modal attention mechanisms to integrate these diverse signals, a dual-stream design effectively fuses haemodynamic and electrophysiological data. The system uses signal augmentation, normalisation, and class-weighted optimisation techniques to tackle issues including noise, high dimensionality, and small dataset sizes. With an AUC of 0.95 and balanced accuracy of 93.75%, the experimental results show good predictive performance while preserving physiological interpretability consistent with established brain biomarkers. Interestingly, the framework achieves a low error rate of 6.5%. Additionally, by producing clinically significant reports from intricate signal representations, the incorporation of generative AI improves interpretability. By facilitating the early detection of neurodegenerative diseases, this work advances SDG 3: Good Health and Well-Being; supports SDG 9: Industry, Innovation, and Infrastructure by creating sophisticated signal processing-driven healthcare systems; and advances SDG 10: Reduced Inequalities by making diagnostic technologies accessible and affordable.

Förderung

  • Amrita Vishwa Vidyapeetham, Coimbatore

Zitieren

APA

Govindarajan, P., Ananthu, M., Sarun, S., Kashyap, S., & Batumalay, M. (2026). NeuroCognex multimodal brain signal analysis for Alzheimer disease prediction. Discover Applied Sciences, 8(11). https://doi.org/10.1007/s42452-026-09323-4

Vancouver

Govindarajan P, Ananthu M, Sarun S, Kashyap S, Batumalay M. NeuroCognex multimodal brain signal analysis for Alzheimer disease prediction. Discover Applied Sciences. 2026;8(11). doi:10.1007/s42452-026-09323-4

BibTeX
@article{Govindarajan2026,
  author = {Govindarajan, Priya and Ananthu, M. and Sarun, S. and Kashyap, Sneha and Batumalay, Malathy},
  title = {NeuroCognex multimodal brain signal analysis for Alzheimer disease prediction},
  journal = {Discover Applied Sciences},
  year = {2026},
  volume = {8},
  number = {11},
  doi = {10.1007/s42452-026-09323-4}
}
Kostenlos starten →